US EditionIt is not business as usual when Indian generic drug producer exports synthetic opioids
Summary by sciencechronicle.in
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
It is not business as usual when Indian generic drug producer exports synthetic opioids
The pharmacy of the global South is facing a crisis of reputation. After cough syrups made by pharmaceutical companies based in India, which had unacceptable amounts of diethylene glycol and/or ethylene glycol, killed 66 children in the Gambia, 65 children in Uzbekistan in 2022, and 12 children in Cameroon in 2023, and India-made eye drops contaminated by drug-resistant bacteria killed three … Continue reading It is not business as usual when In…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
